Guo et al. reported that IL-17RB knockdown in MOLM-13 AML cells had a stronger effect than IL-17B knockdown in vivo, reflecting the potential contribution of microenvironment-derived IL-17B [51]. Here, IL17B is linked to acute myeloid leukemia.